AMAL Therapeutics (AMAL) is a biotech, developing unique therapeutic vaccines and a distinct unit of the Discovery Research organization of the Boehringer Ingelheim group of companies.

Our aim is to overcome the challenges around effective anti-cancer therapy by stimulating a patient’s immune system in a unique way, in order to create immunological memory, as well as target a broad range of patients.